Texas Medicaid holds off on proposed limits for Gilead hepatitis drug

(Reuters) - Texas is reconsidering whether to impose strict limits on Gilead Sciences' $84,000 hepatitis C treatment for patients on the state's Medicaid health plan for the poor, at the urging of outside advisers, a state official said on Friday.

via Reuters: Health News Read More Here..